MedTrace Logo

Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

NCT06368102 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-09-24

No results posted yet for this study

Summary

The purpose of this study is to determine the incidence of surgical site infection (SSIs) after third molar surgery for different duration of intravenous ampicillin administration.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Ampicillin

Total 2g vs 3g

Sponsors & Collaborators

  • Uji Takeda Hospital

    lead OTHER

Principal Investigators

  • Keita Kano, PhD · Uji Takeda Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2025-08-01
Completion
2025-09-01

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06368102 on ClinicalTrials.gov